iSpecimen (NASDAQ:ISPC) Stock Price Down 9.5% – Here’s What Happened

iSpecimen Inc. (NASDAQ:ISPC)’s share price dropped 9.5% during trading on Tuesday . The stock traded as low as $1.32 and last traded at $1.33. 210,799 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,645,295 shares. The stock had previously closed at $1.47.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of iSpecimen in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, iSpecimen has an average rating of “Sell”.

iSpecimen Price Performance

The stock has a 50 day simple moving average of $1.96 and a two-hundred day simple moving average of $4.03. The company has a market cap of $3.35 million, a PE ratio of -0.02 and a beta of 1.62.

iSpecimen (NASDAQ:ISPC) last announced its earnings results on Friday, August 14th. The company reported ($0.98) earnings per share (EPS) for the quarter. The business had revenue of $0.15 million for the quarter. iSpecimen had a negative return on equity of 524.39% and a negative net margin of 2,445.40%.

iSpecimen Company Profile

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.